Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Allergy Therapeutics plc    AGY   GB00B02LCQ05

ALLERGY THERAPEUTICS PLC

(AGY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.
Sales per Businesses
20182019Delta
GBP (in Million)%GBP (in Million)%
Pharmaceutical Products68.35100%73.72100% +7.86%
Sales per Regions
20182019Delta
GBP (in Million)%GBP (in Million)%
Germany42.0261.5%45.0261.1% +7.14%
Other Central Europe9.6714.2%10.9714.9% +13.39%
Spain6.559.6%7.319.9% +11.56%
Italy5.147.5%4.996.8% -2.9%
Rest of World2.493.6%---
United Kingdom1.832.7%---
Other Southern Europe0.6440.9%0.6820.9% +5.9%
Rest of World (including United Kingdom)--4.756.4%-
Managers
NameAgeSinceTitle
Manuel Llobet542012Chief Executive Officer & Executive Director
Peter Sinclair Jensen692011Non-Executive Chairman
Bev Lees-1998Group Director-Operations
Nicolas Alexander Ulrich Wykeman54-Chief Financial Officer & Executive Director
Murray Skinner, Dr.-2004Chief Scientific Officer
Stephen Rushworth Smith662012Senior Independent Non-Executive Director
Babatunde Adekunle Otulana, Dr.622017Non-Executive Director
Scott Leinenweber-2018Non-Executive Director
Mary Geraldine Tavener572019Non-Executive Director
Sara Goldsbrough-2016Secretary
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 636,168,616 106,967,958 16.8% 0 0.0% 16.8%
Stock B 0 9,848,333 0 0.0% 0 0.0%
Shareholders
NameEquities%
Abbott Laboratories 240,584,571 37.8%
Southern Fox Investments Ltd. 127,238,783 20.0%
Skygem Acquisition Ltd. 124,020,708 19.5%
River & Mercantile Asset Management LLP 30,350,000 4.77%
Invesco Asset Management Ltd. 28,618,373 4.50%
M&G Investment Management Ltd. 16,807,764 2.64%
JPMorgan Investment Management, Inc. 14,857,000 2.34%
FIL Investment Advisors (UK) Ltd. 14,486,613 2.28%
Odey Asset Management LLP 14,212,637 2.23%
Hargreaves Lansdown Stockbrokers Ltd. 11,389,000 1.79%
Company contact information
Allergy Therapeutics Plc
Dominion Way
Worthing, West Sussex BN14 8SA

Phone : +44.1903.844.700
Fax : +44.1903.844.726
Web : http://allergytherapeutics.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ALLERGY THERAPEUTICS PLC13.66%97
JOHNSON & JOHNSON2.92%395 123
ROCHE HOLDING AG9.79%294 912
NOVARTIS4.27%220 633
MERCK AND COMPANY-9.13%210 426
PFIZER-6.81%202 051
BRISTOL-MYERS SQUIBB COMPANY3.41%149 421
NOVO NORDISK AS11.65%148 645
ABBVIE INC.6.22%139 083
ELI LILLY AND COMPANY7.37%135 494
AMGEN INC.-7.30%131 810
SANOFI2.92%125 396
ASTRAZENECA PLC-4.04%124 785
GLAXOSMITHKLINE-6.21%108 174
BAYER AG6.26%82 414
ALLERGAN PLC3.74%65 104
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.02%60 987
CHUGAI PHARMACEUTICAL CO., LTD.19.00%59 351
JIANGSU HENGRUI MEDICINE CO., LTD.4.49%57 710
DAIICHI SANKYO COMPANY, LIMITED8.19%45 673
ASTELLAS PHARMA INC.2.97%32 274